JENTADUETO
JENTADUETO
Approved
DIN Number
02403250
Drug Class
Human
Market Date
Apr 17, 2013
Company
HC
boehringer ingelheim (canada) ltd ltee
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02403250
AIG Number0254133001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A10BD11 METFORMIN AND LINAGLIPTIN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:20.05
Health Canada Classification
ACTIVE INGREDIENTS (2)
LINAGLIPTINActive
Strength: 2.5 MG
Monograph: LINAGLIPTIN
METFORMIN HYDROCHLORIDEActive
Strength: 500 MG
Monograph: METFORMIN HYDROCHLORIDE